Selected study cohort characteristics | Double diabetes in participant with normal BMI | |
---|---|---|
No (n = 36) | Yes (n = 14) | |
Age at clinic (years) | 24.5 (21.0-35.8) | 39.0 (23.0-63.8)* |
Age at diagnosis (years) | 18.0 (11.0-24.5) | 17.0 (11.3–51.8) |
Diabetes duration (years) | 9.0 (2.0–17.0) | 9.5 (5.8–18.8) |
Female [n (%)] | 16 (44) | 6 (43) |
Body weight (kg) | 63.4 (60.3–73.1) | 67.3 (59.6–75.0) |
BMI (kg/m2) | 22.6 (20.1–23.5) | 23.2 (22.0-24.6) |
HbA1c (mmol/mol) | 65.0 (55.0-74.8) | 88.5 (70.8-105.3)* |
Total Insulin dose (units) | 42.0 (30.6–50.3) | 41.5 (31.5–58.3) |
Insulin dose (unit/kg/day) | 0.65 (0.47–0.77) | 0.68 (0.50–0.76) |
Total Cholesterol (mmol/L) | 3.8 (3.4–4.9) | 4.3 (3.7–5.4) |
Triglyceride (mmol/L) | 0.9 (0.7–1.3) | 1.3 (0.8–1.6) |
HDL Cholesterol (mmol/L) | 1.6 (1.3–1.9) | 1.6 (1.4-2.0) |
LDL Cholesterol (mmol/L) | 2.0 (1.6–2.5) | 2.2 (1.9-3.0) |
Hypertension, [n (%)] | 0 (0) | 4 (29)* |
Statins [n (%)] | 7 (19) | 4 (29) |
ACEI/ARB [n (%)] | 2 (6) | 2 (14) |
Metformin [n (%)] | 4 (11) | 3 (21) |
Microalbuminuria, [n (%)] | 0 (0) | 5 (36)* |
eGDR | 9.0 (8.6–10.0) | 7.1 (5.6–7.4)* |